Skip to main content

Introducing Zynomi CDP

Zynomi serves as an innovative platform in the domain of clinical trials, providing a comprehensive mobile application that unites participants, healthcare providers, and clinical researchers. The application aims to streamline various facets of the clinical trial process, incorporating medication tracking, enhanced communication channels, and features designed to simplify intricate procedures.

The emphasis is on ensuring compliance and facilitating real-time data exchange. The intent behind Zynomi is to enhance clinical trial management, increase patient engagement, and improve research outcomes through the integration of advanced technology.


Business Features & User Personas

The Zynomi app is tailored for the administration of clinical trials, featuring various actors and modules that work in tandem to ensure a seamless experience.

Key Actors:

  • Volunteers/Patients: Individuals participating in clinical trials who utilize the app for medication tracking, viewing health history, and receiving medication reminders.
  • Healthcare Providers: Doctors and nurses who monitor patient compliance, manage medication schedules, and access patient health data.
  • Clinical Researchers: Users who analyze aggregated data for insights into trial progress and patient adherence.

Essential Modules:

  • Medication Tracking: Enables patients to log their medication intake and view schedules.
  • Reminder System: Sends notifications to patients for upcoming medication doses.
  • Patient Profile Management: Allows the entry and viewing of vital health and medical history.
  • Provider Dashboard: Offers healthcare providers a comprehensive view of patient adherence and health metrics.
  • Reporting and Analytics: Equipped with tools like Grafana dashboards for researchers to analyze clinical trial data.
  • Security and Access Control: Ensures data integrity and privacy compliance.

Together, these components work to optimize trial management, enhance data accuracy, and improve the overall trial experience for all stakeholders.